Capstan Therapeutics
San Diego, US · Founded 2020 · Delaware corporation · 4 known investors
AbbVie is a biopharmaceutical company that discovers and delivers medicines for immune-mediated diseases and other therapeutic areas globally.
Founders & leadership
AB
Adrian BotExecutive
LS
Laura ShawverExecutive
RF
Ramin Farzaneh-FarExecutive
JT
Justin ThackerNamed on SEC filing
KS
Karen SmithNamed on SEC filing
FP
Fabio PucciNamed on SEC filing
MS
Michal SilverbergNamed on SEC filing
MB
Michael BaranNamed on SEC filing
RJ
Rajul JainNamed on SEC filing
Board
NS
NL
Nanna LuneborgBoard director
EC
Erez ChimovitsBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$227M disclosed across 3 rounds · 2021–2024
▶$76.5MraisedMar 2024 · 14 investors · BiotechnologyRule 506(b)
▶$76.5MraisedMar 2024 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Justin ThackerExecutive Officer
- Karen SmithDirector
- Fabio PucciDirector
- Nandita ShangariDirector
- Adrian BotExecutive Officer
- Michal SilverbergDirector
- Laura ShawverExecutive Officer, Director
- Nanna LuneborgDirector
- Michael BaranDirector
- Erez ChimovitsDirector
- Ramin Farzaneh-FarExecutive Officer
- Rajul JainDirector
- Priya KarmaliExecutive Officer
- Athena CountouriotisDirector
- Offering amount
- $102M
- Amount sold
- $76.5M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$63MraisedMar 2024 · 9 investors · BiotechnologyRule 506(b)
▶$63MraisedMar 2024 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michal SilverbergDirector
- Fabio PucciDirector
- Ramin Farzaneh-FarExecutive Officer
- Rajul JainDirector
- Laura ShawverExecutive Officer, Director
- Nanna LuneborgDirector
- Nandita ShangariDirector
- Karen SmithDirector
- Justin ThackerExecutive Officer
- Adrian BotExecutive Officer
- Erez ChimovitsDirector
- Priya KarmaliExecutive Officer
- Michael BaranDirector
- Athena CountouriotisDirector
- Offering amount
- $63M
- Amount sold
- $63M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$87.5MraisedMar 2024 · 21 investors · BiotechnologyRule 506(b)
▶$87.5MraisedMar 2024 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Fabio PucciDirector
- Nandita ShangariDirector
- Michal SilverbergDirector
- Erez ChimovitsDirector
- Athena CountouriotisDirector
- Rajul JainDirector
- Laura ShawverExecutive Officer, Director
- Ramin Farzaneh-FarExecutive Officer
- Justin ThackerExecutive Officer
- Michael BaranDirector
- Adrian BotExecutive Officer
- Nanna LuneborgDirector
- Priya KarmaliExecutive Officer
- Karen SmithDirector
- Offering amount
- $175M
- Amount sold
- $87.5M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Capstan Therapeutics do?
- AbbVie is a biopharmaceutical company that discovers and delivers medicines for immune-mediated diseases and other therapeutic areas globally.
- Who are Capstan Therapeutics's investors?
- Capstan Therapeutics's investors include Pfizer Venture Investments, RA Capital, Sofinnova Ventures, Vida Ventures.
- How much funding has Capstan Therapeutics raised?
- Capstan Therapeutics has disclosed $227M raised across 3 rounds.
- Where is Capstan Therapeutics headquartered?
- Capstan Therapeutics is headquartered in San Diego, US.